Advances in Understanding and Treating MPNs

Published on

Topics include: Treatments and Understanding

Dr. Srdan Verstovsek, a world-renowned researcher from MD Anderson Cancer Center, explores what he describes as "unprecedented developments" in the understanding of myeloproliferative neoplasms (MPNs). Dr. Verstovsek explains how  these developments could lead to more effective treatment options for people with essential thrombocythemia (ET), myelofibrosis (PMF) and polycythemia vera (PV).

View more programs featuring

Produced in association with

Related Programs

Mike Harris: Enjoying a Full Life Despite Myelofibrosis

Mike Harris choses to live a full life with myelofibrosis, continuing to hunt, fish and help support other patients learning to live with the challenges of having a chronic illness.


Exciting Data on Developing Drugs for Myelofibrosis

Over the past year, there has been continued progress in improving treatments for myelofibrosis. Watch now as Dr. Claire Harrison shares updated news from the Comfort II study, including how patients are responding to the treatment regimen with few side effects.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on November 26, 2013